NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000015168

Registered date:16/09/2014

Investigation of optimal regimen of Fulvestrant in patients with postmenopausal ER-positive advanced recurrent breast cancer

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedPatients with postmenopausal ER-positive advanced recurrent breast cancer
Date of first enrollment2014/10/01
Target sample size1000
Countries of recruitmentJapan
Study typeObservational
Intervention(s)

Outcome(s)

Primary OutcomeEffects of clinical background and prior therapies on the treatment time with Fulvestrant (TTF)
Secondary OutcomeSecondary analysis 1.Effects of clinical background and prior therapies on overall survival (OS) after start of Fulvestrant 2.Descriptive statistics of treatment 3.Summary of therapies administered to subjects with long survival

Key inclusion & exclusion criteria

Age minimumNot applicable
Age maximumNot applicable
GenderFemale
Include criteria
Exclude criteria1)Patients not agree with this study

Related Information

Contact

public contact
Name Katsumasa Kuroi
Address 9-4-3F, Nihonbashikoamicho, Chuo-ku, Tokyo, Japan Japan 103-0016
Telephone 03-6264-8873
E-mail office@jbcrg.jp
Affiliation Japan Breast Cancer Research Group (JBCRG) Adminstrative office
scientific contact
Name 1)Hidetoshi 2)Shinji 1)Kawaguchi 2)Ohno
Address 1) 1 Bunkyo-cho , Matsuyama-shi, Ehime Japan Japan
Telephone 089-924-1111
E-mail hkawaguchi@matsuyama.jrc.or.jp
Affiliation 1) Matsuyama Red Cross Hospital 2) The Cancer Institute Hospital Of JFCR 1) Department of breast surgery 2) Breast Oncology Center